Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Comment by Onedaylateon Oct 26, 2016 9:22pm

95 Views

Post# 25390597

RE:RE:From Stockwatch Gold Summary

I was wondering the exact same thing. With those kind of returns, a mine should be up and running.
When I looked at it all I get for reasons that work was discontinued was because of inclement weather, and the fact that they were in the pathway of a glacier. But thanks to global warming the glacier is receeding.
Don't know if any of that is true. But what is obvious is the PLS drill program in Sask. That chewed up at least two years along with a lot of money. It ended up as a failure.
Hind site is 20-20, and it's easy to be an armchair CEO. But with the drill results they did get at Clone, how do you delay work there in favour for a complete unkown at PLS?

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale